Vita Life Sciences Limited (ASX:VLS) Insider Henry Townsing Sells 100,000 Shares

Vita Life Sciences Limited (ASX:VLS) insider Henry Townsing sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of A$2.10 ($1.35), for a total value of A$210,000.00 ($135,483.87).

Henry Townsing also recently made the following trade(s):

• On Wednesday, March 27th, Henry Townsing 300,000 shares of Vita Life Sciences stock.

Vita Life Sciences Price Performance

The company has a current ratio of 2.98, a quick ratio of 1.57 and a debt-to-equity ratio of 0.89.

Vita Life Sciences Increases Dividend

The business also recently disclosed a Final dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, April 11th were given a $0.06 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a yield of 2.6%. This is an increase from Vita Life Sciences’s previous Final dividend of $0.03. Vita Life Sciences’s payout ratio is presently 52.94%.

Vita Life Sciences Company Profile

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints.